Cresset Asset Management, LLC Vertex Pharmaceuticals Inc Transaction History

Cresset Asset Management, LLC

$23.6 Billion
Q2 2024

A detailed history of Cresset Asset Management, LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Cresset Asset Management, LLC holds 100 shares of VRTX stock, worth $46,288. This represents 0.0% of its overall portfolio holdings.

Number of Shares

100

Previous 12,034 99.17%

Holding current value

$46,288

Previous $5.03 Million 99.09%

% of portfolio

0.0%

Previous 0.02%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$392.81 - $485.53 $1.57 Million - $1.94 Million	4,005 Added 33.28%	16,039 $7.52 Million
Q1 2024 May 15, 2024	BUY	$407.69 - $446.08 $391,790 - $428,682	961 Added 8.68%	12,034 $5.03 Million
Q4 2023 Feb 14, 2024	BUY	$343.0 - $410.68 $620,144 - $742,509	1,808 Added 19.51%	11,073 $4.51 Million
Q3 2023 Nov 14, 2023	SELL	$338.18 - $362.46 $417,314 - $447,275	-1,234 Reduced 11.75%	9,265 $3.22 Million
Q2 2023 Aug 14, 2023	BUY	$314.42 - $351.91 $2.86 Million - $3.21 Million	9,110 Added 655.87%	10,499 $3.69 Million
Q1 2023 May 12, 2023	BUY	$283.23 - $323.1 $393,406 - $448,785	1,389 New	1,389 $437,000
Q3 2022 Nov 14, 2022	SELL	$273.83 - $305.53 $94,471 - $105,407	-345 Reduced 15.99%	1,812 $524,000
Q2 2022 Aug 15, 2022	SELL	$234.96 - $292.55 $199,716 - $248,667	-850 Reduced 28.27%	2,157 $605,000
Q1 2022 May 16, 2022	BUY	$221.42 - $260.97 $100,303 - $118,219	453 Added 17.74%	3,007 $785,000
Q4 2021 Feb 10, 2022	SELL	$177.01 - $223.45 $82,309 - $103,904	-465 Reduced 15.4%	2,554 $560,000
Q3 2021 Nov 15, 2021	BUY	$181.39 - $202.99 $91,057 - $101,900	502 Added 19.94%	3,019 $548,000
Q2 2021 Aug 10, 2021	BUY	$187.49 - $221.1 $28,498 - $33,607	152 Added 6.43%	2,517 $508,000
Q1 2021 May 12, 2021	BUY	$207.02 - $241.31 $121,106 - $141,166	585 Added 32.87%	2,365 $508,000
Q4 2020 Feb 11, 2021	SELL	$207.01 - $276.09 $65,622 - $87,520	-317 Reduced 15.12%	1,780 $421,000
Q3 2020 Nov 13, 2020	BUY	$255.65 - $303.1 $42,182 - $50,011	165 Added 8.54%	2,097 $570,000
Q2 2020 Aug 04, 2020	BUY	$225.48 - $295.8 $122,210 - $160,323	542 Added 38.99%	1,932 $561,000
Q1 2020 May 15, 2020	BUY	$199.77 - $247.81 $50,541 - $62,695	253 Added 22.25%	1,390 $331,000
Q4 2019 Feb 10, 2020	BUY	$166.71 - $223.91 $189,549 - $254,585	1,137 New	1,137 $249,000
Q3 2019 Nov 13, 2019	SELL	$166.23 - $187.09 $201,470 - $226,753	-1,212 Closed	0 $0
Q2 2019 Aug 12, 2019	BUY	$164.61 - $190.37 $17,119 - $19,798	104 Added 9.39%	1,212 $222,000
Q1 2019 May 15, 2019	BUY	$163.73 - $194.7 $98,565 - $117,209	602 Added 118.97%	1,108 $204,000
Q4 2018 May 21, 2019	BUY	$151.91 - $192.21 $76,866 - $97,258	506 New	506 $84,000

Others Institutions Holding VRTX

# of Institutions

1,707

Shares Held

226M

Call Options Held

1.2M

Put Options Held

1.59M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $119B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cresset Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cresset Asset Management, LLC with notifications on news.

Account

Cresset Asset Management, LLC Vertex Pharmaceuticals Inc Transaction History